Alamar Biosciences Certifies Securities Listing Approval

Ticker: ALMR · Form: CERT · Filed: Apr 16, 2026

Sentiment: neutral

Topics: listing, certification, regulatory

Related Tickers: ALMR

TL;DR

ALMR securities approved for listing effective 4/16/2026. Big win.

AI Summary

Alamar Biosciences, Inc. filed a CERT form on April 16, 2026, to certify the approval of securities for listing. The filing, with SEC Accession No. 0001354457-26-000353, indicates that the effectiveness date for this approval is also April 16, 2026. The company's mailing and business address is 47071 BAYSIDE PARKWAY, FREMONT CA 94538.

Why It Matters

This filing confirms that Alamar Biosciences, Inc.'s securities have been approved for listing, a crucial step for public trading and investor confidence.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming securities listing approval, not indicating new financial risks.

Key Numbers

Key Players & Entities

FAQ

What type of filing is this?

This is a CERT form, which certifies the approval of securities for listing.

When was the filing accepted and effective?

The filing was accepted and became effective on April 16, 2026.

What is the SEC Accession Number for this filing?

The SEC Accession Number is 0001354457-26-000353.

What is Alamar Biosciences, Inc.'s CIK number?

Alamar Biosciences, Inc.'s CIK number is 0002104204.

Where is Alamar Biosciences, Inc. located?

Alamar Biosciences, Inc.'s mailing and business address is 47071 BAYSIDE PARKWAY, FREMONT CA 94538.

Filing Details

This Form CERT (Form CERT) was filed with the SEC on April 16, 2026 regarding Alamar Biosciences, Inc. (ALMR).

View full filing on EDGAR

View on Read The Filing